News

The regulator is warning people to store their medicine properly, drink more water and check their risks in heatwaves ...
Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...
Thomas Hirschi, head of the Banks division of the Swiss Financial Market Supervisory Authority FINMA will leave at the end of ...
To get a handle on this growing complexity, especially around communications compliance in tightly regulated industries like ...
Astra said its experimental drug Baxdrostat reduced the blood pressure of patients who have a treatment-resistant form of ...
For-profit rehab hospitals, including industry giant Encompass Health, have faced serious patient safety violations and deaths, yet federal oversight lacks penalties and transparency, leaving ...
Hot temperatures can cause some medications and devices to malfunction, while others could make you more vulnerable to the ...
AstraZeneca’s drug candidate baxdrostat lowered systolic blood pressure in a phase 3 clinical trial involving patients with uncontrolled or treatment-resistant hypertension. In the trial, patients who ...
New Jersey environmental regulators are amending a proposal that has faced harsh criticism from builders and the business community.
Apparent gaps in AAIB’s preliminary report means that while a key factor in the disaster—cutting of the fuel supply—has been ...
As the financial services sector focuses on sustainability, innovative technologies will be vital to support operations and ...